Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
69,579
Sort by:
Barth Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Barth Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Barth Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...
May 2022
36 pages
Benign Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Benign Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Benign Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...
May 2022
81 pages
Biliary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Biliary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Biliary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...
May 2022
52 pages
Bipolar Disorder (Manic Depression) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Bipolar Disorder (Manic Depression) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bipolar Disorder (Manic Depression) Drugs in Development by Stages, Target,...
May 2022
75 pages
Bleeding And Clotting Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Bleeding And Clotting Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bleeding And Clotting Disorders Drugs in Development by Stages, Target, MoA, RoA...
May 2022
266 pages
Blepharospasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Blepharospasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Blepharospasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...
May 2022
36 pages
Blood Coagulation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Blood Coagulation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Blood Coagulation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...
May 2022
45 pages
Bone Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Bone Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...
May 2022
263 pages
Bone Fracture Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Bone Fracture Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Fracture Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...
May 2022
61 pages
Bone Regeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Bone Regeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Regeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...
May 2022
43 pages
Bone Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Bone Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...
May 2022
236 pages
Born Small For Gestational Age (SGA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Born Small For Gestational Age (SGA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Born Small For Gestational Age (SGA) Drugs in Development by Stages, Target...
May 2022
35 pages
Brain Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Brain Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Brain Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...
May 2022
161 pages
Brain (Head) Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Brain (Head) Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Brain (Head) Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...
May 2022
35 pages
Brain Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Brain Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Brain Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...
May 2022
50 pages
Brain Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Brain Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Brain Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...
May 2022
119 pages
Bronchiolitis Obliterans Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Bronchiolitis Obliterans Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bronchiolitis Obliterans Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...
May 2022
39 pages
Burkholderia Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Burkholderia Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Burkholderia Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...
May 2022
45 pages
Burkitt Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Burkitt Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Burkitt Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...
May 2022
94 pages
Cachexia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Cachexia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cachexia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an ov...
May 2022
51 pages
cAMP Specific 3,5 Cyclic Phosphodiesterase 4B (DPDE4 or PDE32 or PDE4B or EC 3.1.4.53) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
cAMP Specific 3,5 Cyclic Phosphodiesterase 4B (DPDE4 or PDE32 or PDE4B or EC 3.1.4.53) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY cA...
May 2022
36 pages
Carcinoid Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Carcinoid Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Carcinoid Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...
May 2022
40 pages
Carcinomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Carcinomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Carcinomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...
May 2022
266 pages
Cardiometabolic Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Cardiometabolic Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cardiometabolic Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...
May 2022
47 pages